5 reagents for use in veterinary genetic testing for medical use; chemical preparations for pharmaceutical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; chemical preparations for use in DNA analysis for medical use; drugs for medical purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; reagents for use in medical genetic testing for medical use; pharmaceutical drugs, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; medicines for human purposes, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; pharmaceutical preparations for diagnosis; pharmaceutical preparations for the treatment of immune system related diseases and disorders; ethical medicinal preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; therapeutic drugs and agents, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; crude medicines, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use in medical and clinical gene therapy and cell therapy; pharmaceutical preparations, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer; biological preparations for medical use, namely, for treating neurological disease, muscular disease, ischemic disease, renal disease, cancer